Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

NCT00770965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

BIOLOGICAL: AIN457
BIOLOGICAL: Placebo

Sponsor

Novartis Pharmaceuticals